Detailed Information on Publication Record
2016
Malignant catatonia due to anti-NMDA-receptor encephalitis in a 15-year-old girl: case report and summary of current knowledge
AULICKÁ, Štefánia, Ondřej HORÁK, Lenka MRÁZOVÁ, Peter MIKOLÁŠEK, Jaroslav ŠTĚRBA et. al.Basic information
Original name
Malignant catatonia due to anti-NMDA-receptor encephalitis in a 15-year-old girl: case report and summary of current knowledge
Authors
AULICKÁ, Štefánia (703 Slovakia, guarantor, belonging to the institution), Ondřej HORÁK (203 Czech Republic, belonging to the institution), Lenka MRÁZOVÁ (203 Czech Republic, belonging to the institution), Peter MIKOLÁŠEK (703 Slovakia, belonging to the institution), Jaroslav ŠTĚRBA (203 Czech Republic), Lenka KRBKOVÁ (203 Czech Republic, belonging to the institution) and Hana OŠLEJŠKOVÁ (203 Czech Republic, belonging to the institution)
Edition
Neuropsychiatry, London, Future Medicine Ltd. 2016, 1758-2008
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30000 3. Medical and Health Sciences
Country of publisher
United Kingdom of Great Britain and Northern Ireland
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 4.778
RIV identification code
RIV/00216224:14110/16:00091888
Organization unit
Faculty of Medicine
Keywords in English
NMDA receptor antibodies; malignant catatonia; paraneoplastic form; non-paraneoplastic form; immunotherapy
Tags
Tags
International impact, Reviewed
Změněno: 26/4/2017 12:17, Soňa Böhmová
Abstract
V originále
Anti-N-methyl-D-aspartate receptor encephalitis is a recently identified autoimmune disorder with a prominent neuropsychiatric presentation. We present the case of a 15-yearold girl with partial complex seizures with secondary generalization and acute mania with psychotic features. A positive diagnosis of anti-NMDA-receptor encephalitis suggested the specific treatment. Despite first-line immune treatment, the patient progressed to stupor, malignant catatonia, and autonomic instability with the risk of cardiopulmonary function failure. She improved after second-line immunosuppressive therapy (cyclophosphamide and rituximab simultaneously). Post-cognitive sequelae (memory impairment and deliberation) disappeared within 8 months of follow-up treatment and intensive cognitive rehabilitation. This case report emphasizes the importance of differential diagnosis and adequate treatment of catatonic syndrome, especially in young adults. Early recognition and adequate treatment is essential for a good outcome for the patients.
Links
ROZV/24/LF/2016, interní kód MU |
|